Corvus Pharmaceuticals, Inc.CRVSNASDAQ
Loading
Other Income/Expenses (Net) Over TimeExpanding
Percentile Rank91
5Y CAGR-6.0%
Year-over-Year Change
Net other income and expenses outside core operations
5Y CAGR
-6.0%/yr
Long-term compound
Percentile
P91
Near historical high
vs 5Y Ago
0.7x
Contraction
Streak
1 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $27.69M | +179.7% |
| 2024 | $-34.74M | -859.3% |
| 2023 | $-3.62M | +58.6% |
| 2022 | $-8.74M | -89.6% |
| 2021 | $-4.61M | -112.2% |
| 2020 | $37.77M | +1630.8% |
| 2019 | $2.18M | -4.4% |
| 2018 | $2.28M | +165.2% |
| 2017 | $861000.00 | +43.3% |
| 2016 | $601000.00 | - |